GO:0006413 | translational initiation | 1.42e-09 | 2.04e-05 | 5.560 | 6 | 17 | 131 |
GO:0042273 | ribosomal large subunit biogenesis | 2.07e-07 | 2.99e-03 | 7.893 | 3 | 4 | 13 |
GO:0019083 | viral transcription | 8.85e-07 | 1.28e-02 | 5.669 | 4 | 10 | 81 |
GO:0005829 | cytosol | 8.90e-07 | 1.28e-02 | 2.183 | 11 | 132 | 2496 |
GO:0010467 | gene expression | 1.16e-06 | 1.67e-02 | 3.430 | 7 | 59 | 669 |
GO:0006415 | translational termination | 1.18e-06 | 1.70e-02 | 5.566 | 4 | 10 | 87 |
GO:0016071 | mRNA metabolic process | 1.51e-06 | 2.18e-02 | 4.530 | 5 | 31 | 223 |
GO:0006414 | translational elongation | 1.54e-06 | 2.23e-02 | 5.470 | 4 | 13 | 93 |
GO:0006412 | translation | 1.76e-06 | 2.54e-02 | 4.485 | 5 | 20 | 230 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 2.42e-06 | 3.48e-02 | 5.308 | 4 | 10 | 104 |
GO:0016070 | RNA metabolic process | 2.50e-06 | 3.60e-02 | 4.382 | 5 | 32 | 247 |
GO:0044267 | cellular protein metabolic process | 2.93e-06 | 4.22e-02 | 3.705 | 6 | 29 | 474 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 3.49e-06 | 5.03e-02 | 5.176 | 4 | 11 | 114 |
GO:0019058 | viral life cycle | 3.61e-06 | 5.21e-02 | 5.163 | 4 | 13 | 115 |
GO:0016020 | membrane | 4.50e-06 | 6.49e-02 | 2.464 | 9 | 90 | 1681 |
GO:0016032 | viral process | 5.84e-06 | 8.42e-02 | 3.533 | 6 | 55 | 534 |
GO:0003735 | structural constituent of ribosome | 7.24e-06 | 1.04e-01 | 4.911 | 4 | 10 | 137 |
GO:0022625 | cytosolic large ribosomal subunit | 1.31e-05 | 1.88e-01 | 5.979 | 3 | 6 | 49 |
GO:0070062 | extracellular vesicular exosome | 8.64e-05 | 1.00e+00 | 1.950 | 9 | 104 | 2400 |
GO:0003723 | RNA binding | 2.58e-04 | 1.00e+00 | 3.591 | 4 | 20 | 342 |
GO:0044822 | poly(A) RNA binding | 2.73e-04 | 1.00e+00 | 2.549 | 6 | 49 | 1056 |
GO:0019843 | rRNA binding | 3.03e-04 | 1.00e+00 | 6.254 | 2 | 3 | 27 |
GO:0043022 | ribosome binding | 3.03e-04 | 1.00e+00 | 6.254 | 2 | 3 | 27 |
GO:0030669 | clathrin-coated endocytic vesicle membrane | 3.26e-04 | 1.00e+00 | 6.201 | 2 | 4 | 28 |
GO:0004151 | dihydroorotase activity | 9.71e-04 | 1.00e+00 | 10.009 | 1 | 1 | 1 |
GO:0019521 | D-gluconate metabolic process | 9.71e-04 | 1.00e+00 | 10.009 | 1 | 1 | 1 |
GO:0000054 | ribosomal subunit export from nucleus | 9.71e-04 | 1.00e+00 | 10.009 | 1 | 1 | 1 |
GO:0004070 | aspartate carbamoyltransferase activity | 9.71e-04 | 1.00e+00 | 10.009 | 1 | 1 | 1 |
GO:0004088 | carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity | 9.71e-04 | 1.00e+00 | 10.009 | 1 | 1 | 1 |
GO:0070335 | aspartate binding | 9.71e-04 | 1.00e+00 | 10.009 | 1 | 1 | 1 |
GO:0003743 | translation initiation factor activity | 1.00e-03 | 1.00e+00 | 5.394 | 2 | 8 | 49 |
GO:0005048 | signal sequence binding | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 2 |
GO:0000461 | endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 2 |
GO:0019322 | pentose biosynthetic process | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 2 | 2 |
GO:0005055 | laminin receptor activity | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 2 |
GO:0006407 | rRNA export from nucleus | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 2 |
GO:0070409 | carbamoyl phosphate biosynthetic process | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 2 |
GO:0043234 | protein complex | 2.61e-03 | 1.00e+00 | 3.389 | 3 | 18 | 295 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 3 |
GO:1900126 | negative regulation of hyaluronan biosynthetic process | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 2 | 3 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 2 | 3 |
GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 3 |
GO:0044205 | 'de novo' UMP biosynthetic process | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 3 |
GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 3 |
GO:0071439 | clathrin complex | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 2 | 3 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 3.34e-03 | 1.00e+00 | 4.517 | 2 | 7 | 90 |
GO:0006364 | rRNA processing | 3.63e-03 | 1.00e+00 | 4.454 | 2 | 6 | 94 |
GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 4 |
GO:0030686 | 90S preribosome | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 4 |
GO:0032051 | clathrin light chain binding | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 4 |
GO:0006543 | glutamine catabolic process | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 4 |
GO:1903077 | negative regulation of protein localization to plasma membrane | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 4 |
GO:0032549 | ribonucleoside binding | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 2 | 4 |
GO:0005925 | focal adhesion | 4.79e-03 | 1.00e+00 | 3.078 | 3 | 19 | 366 |
GO:0051414 | response to cortisol | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 5 |
GO:0042256 | mature ribosome assembly | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 5 |
GO:0043248 | proteasome assembly | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 5 |
GO:0005638 | lamin filament | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 5 |
GO:0043023 | ribosomal large subunit binding | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 5 |
GO:0030130 | clathrin coat of trans-Golgi network vesicle | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 3 | 6 |
GO:0030957 | Tat protein binding | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 3 | 6 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 1 | 6 |
GO:0030118 | clathrin coat | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 2 | 6 |
GO:0030132 | clathrin coat of coated pit | 6.78e-03 | 1.00e+00 | 7.201 | 1 | 2 | 7 |
GO:0000028 | ribosomal small subunit assembly | 6.78e-03 | 1.00e+00 | 7.201 | 1 | 1 | 7 |
GO:0035615 | clathrin adaptor activity | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 2 | 8 |
GO:0070688 | MLL5-L complex | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 1 | 8 |
GO:0061024 | membrane organization | 8.44e-03 | 1.00e+00 | 3.829 | 2 | 7 | 145 |
GO:0006228 | UTP biosynthetic process | 8.70e-03 | 1.00e+00 | 6.839 | 1 | 1 | 9 |
GO:0014075 | response to amine | 8.70e-03 | 1.00e+00 | 6.839 | 1 | 1 | 9 |
GO:0031000 | response to caffeine | 8.70e-03 | 1.00e+00 | 6.839 | 1 | 2 | 9 |
GO:0006098 | pentose-phosphate shunt | 9.67e-03 | 1.00e+00 | 6.687 | 1 | 4 | 10 |
GO:0030122 | AP-2 adaptor complex | 9.67e-03 | 1.00e+00 | 6.687 | 1 | 2 | 10 |
GO:0005838 | proteasome regulatory particle | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 7 | 12 |
GO:0072583 | clathrin-mediated endocytosis | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 2 | 12 |
GO:0006886 | intracellular protein transport | 1.16e-02 | 1.00e+00 | 3.591 | 2 | 5 | 171 |
GO:0035267 | NuA4 histone acetyltransferase complex | 1.35e-02 | 1.00e+00 | 6.201 | 1 | 4 | 14 |
GO:0050998 | nitric-oxide synthase binding | 1.54e-02 | 1.00e+00 | 6.009 | 1 | 1 | 16 |
GO:0006541 | glutamine metabolic process | 1.64e-02 | 1.00e+00 | 5.921 | 1 | 1 | 17 |
GO:0022624 | proteasome accessory complex | 1.64e-02 | 1.00e+00 | 5.921 | 1 | 8 | 17 |
GO:0017144 | drug metabolic process | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 1 | 18 |
GO:0048863 | stem cell differentiation | 1.83e-02 | 1.00e+00 | 5.761 | 1 | 1 | 19 |
GO:0030276 | clathrin binding | 1.92e-02 | 1.00e+00 | 5.687 | 1 | 2 | 20 |
GO:0071364 | cellular response to epidermal growth factor stimulus | 2.02e-02 | 1.00e+00 | 5.616 | 1 | 1 | 21 |
GO:0006206 | pyrimidine nucleobase metabolic process | 2.12e-02 | 1.00e+00 | 5.549 | 1 | 2 | 22 |
GO:0033574 | response to testosterone | 2.12e-02 | 1.00e+00 | 5.549 | 1 | 2 | 22 |
GO:0030863 | cortical cytoskeleton | 2.12e-02 | 1.00e+00 | 5.549 | 1 | 1 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 2.12e-02 | 1.00e+00 | 5.549 | 1 | 4 | 22 |
GO:0043044 | ATP-dependent chromatin remodeling | 2.21e-02 | 1.00e+00 | 5.485 | 1 | 4 | 23 |
GO:0006362 | transcription elongation from RNA polymerase I promoter | 2.21e-02 | 1.00e+00 | 5.485 | 1 | 3 | 23 |
GO:0043236 | laminin binding | 2.21e-02 | 1.00e+00 | 5.485 | 1 | 1 | 23 |
GO:0008135 | translation factor activity, nucleic acid binding | 2.31e-02 | 1.00e+00 | 5.424 | 1 | 7 | 24 |
GO:0006363 | termination of RNA polymerase I transcription | 2.31e-02 | 1.00e+00 | 5.424 | 1 | 3 | 24 |
GO:0003899 | DNA-directed RNA polymerase activity | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 3 | 25 |
GO:0005515 | protein binding | 2.44e-02 | 1.00e+00 | 0.774 | 10 | 184 | 6024 |
GO:0006361 | transcription initiation from RNA polymerase I promoter | 2.50e-02 | 1.00e+00 | 5.308 | 1 | 3 | 26 |
GO:0050690 | regulation of defense response to virus by virus | 2.59e-02 | 1.00e+00 | 5.254 | 1 | 4 | 27 |
GO:0050661 | NADP binding | 2.59e-02 | 1.00e+00 | 5.254 | 1 | 2 | 27 |
GO:0031492 | nucleosomal DNA binding | 2.59e-02 | 1.00e+00 | 5.254 | 1 | 4 | 27 |
GO:0019894 | kinesin binding | 2.69e-02 | 1.00e+00 | 5.201 | 1 | 1 | 28 |
GO:0034504 | protein localization to nucleus | 2.69e-02 | 1.00e+00 | 5.201 | 1 | 2 | 28 |
GO:0006360 | transcription from RNA polymerase I promoter | 2.87e-02 | 1.00e+00 | 5.102 | 1 | 5 | 30 |
GO:0042254 | ribosome biogenesis | 2.87e-02 | 1.00e+00 | 5.102 | 1 | 1 | 30 |
GO:0033572 | transferrin transport | 2.87e-02 | 1.00e+00 | 5.102 | 1 | 5 | 30 |
GO:0031623 | receptor internalization | 2.97e-02 | 1.00e+00 | 5.055 | 1 | 2 | 31 |
GO:0032588 | trans-Golgi network membrane | 3.25e-02 | 1.00e+00 | 4.921 | 1 | 2 | 34 |
GO:0001895 | retina homeostasis | 3.25e-02 | 1.00e+00 | 4.921 | 1 | 1 | 34 |
GO:0006605 | protein targeting | 3.35e-02 | 1.00e+00 | 4.879 | 1 | 2 | 35 |
GO:0034332 | adherens junction organization | 3.44e-02 | 1.00e+00 | 4.839 | 1 | 1 | 36 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 3.44e-02 | 1.00e+00 | 4.839 | 1 | 4 | 36 |
GO:0018107 | peptidyl-threonine phosphorylation | 3.53e-02 | 1.00e+00 | 4.799 | 1 | 4 | 37 |
GO:0051084 | 'de novo' posttranslational protein folding | 3.53e-02 | 1.00e+00 | 4.799 | 1 | 4 | 37 |
GO:0070527 | platelet aggregation | 3.63e-02 | 1.00e+00 | 4.761 | 1 | 2 | 38 |
GO:0019901 | protein kinase binding | 3.68e-02 | 1.00e+00 | 2.700 | 2 | 21 | 317 |
GO:0022627 | cytosolic small ribosomal subunit | 3.72e-02 | 1.00e+00 | 4.723 | 1 | 4 | 39 |
GO:0007595 | lactation | 3.72e-02 | 1.00e+00 | 4.723 | 1 | 2 | 39 |
GO:0007411 | axon guidance | 3.72e-02 | 1.00e+00 | 2.691 | 2 | 13 | 319 |
GO:0043195 | terminal bouton | 3.91e-02 | 1.00e+00 | 4.651 | 1 | 1 | 41 |
GO:0030136 | clathrin-coated vesicle | 4.00e-02 | 1.00e+00 | 4.616 | 1 | 4 | 42 |
GO:0006892 | post-Golgi vesicle-mediated transport | 4.10e-02 | 1.00e+00 | 4.582 | 1 | 3 | 43 |
GO:0021762 | substantia nigra development | 4.19e-02 | 1.00e+00 | 4.549 | 1 | 2 | 44 |
GO:0035690 | cellular response to drug | 4.65e-02 | 1.00e+00 | 4.394 | 1 | 2 | 49 |
GO:0006521 | regulation of cellular amino acid metabolic process | 4.75e-02 | 1.00e+00 | 4.365 | 1 | 17 | 50 |
GO:0031100 | organ regeneration | 4.75e-02 | 1.00e+00 | 4.365 | 1 | 4 | 50 |
GO:0003725 | double-stranded RNA binding | 4.93e-02 | 1.00e+00 | 4.308 | 1 | 5 | 52 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 5.03e-02 | 1.00e+00 | 4.281 | 1 | 5 | 53 |
GO:0030666 | endocytic vesicle membrane | 5.03e-02 | 1.00e+00 | 4.281 | 1 | 4 | 53 |
GO:0045216 | cell-cell junction organization | 5.12e-02 | 1.00e+00 | 4.254 | 1 | 2 | 54 |
GO:0008565 | protein transporter activity | 5.30e-02 | 1.00e+00 | 4.201 | 1 | 5 | 56 |
GO:0000502 | proteasome complex | 5.49e-02 | 1.00e+00 | 4.151 | 1 | 17 | 58 |
GO:0042995 | cell projection | 5.67e-02 | 1.00e+00 | 4.102 | 1 | 6 | 60 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 6.04e-02 | 1.00e+00 | 4.009 | 1 | 19 | 64 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 6.13e-02 | 1.00e+00 | 3.986 | 1 | 22 | 65 |
GO:0034329 | cell junction assembly | 6.40e-02 | 1.00e+00 | 3.921 | 1 | 1 | 68 |
GO:0005730 | nucleolus | 6.58e-02 | 1.00e+00 | 1.328 | 4 | 69 | 1641 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 6.59e-02 | 1.00e+00 | 3.879 | 1 | 2 | 70 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 6.59e-02 | 1.00e+00 | 3.879 | 1 | 22 | 70 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 6.77e-02 | 1.00e+00 | 3.839 | 1 | 20 | 72 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 6.95e-02 | 1.00e+00 | 3.799 | 1 | 6 | 74 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 6.95e-02 | 1.00e+00 | 3.799 | 1 | 22 | 74 |
GO:0008584 | male gonad development | 7.04e-02 | 1.00e+00 | 3.780 | 1 | 3 | 75 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 7.04e-02 | 1.00e+00 | 3.780 | 1 | 20 | 75 |
GO:0001889 | liver development | 7.22e-02 | 1.00e+00 | 3.742 | 1 | 4 | 77 |
GO:0007565 | female pregnancy | 7.31e-02 | 1.00e+00 | 3.723 | 1 | 1 | 78 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 7.40e-02 | 1.00e+00 | 3.705 | 1 | 23 | 79 |
GO:0006898 | receptor-mediated endocytosis | 7.86e-02 | 1.00e+00 | 3.616 | 1 | 3 | 84 |
GO:0005654 | nucleoplasm | 8.23e-02 | 1.00e+00 | 1.514 | 3 | 76 | 1082 |
GO:0042470 | melanosome | 8.48e-02 | 1.00e+00 | 3.501 | 1 | 9 | 91 |
GO:0016363 | nuclear matrix | 8.48e-02 | 1.00e+00 | 3.501 | 1 | 12 | 91 |
GO:0006928 | cellular component movement | 8.48e-02 | 1.00e+00 | 3.501 | 1 | 7 | 91 |
GO:0005200 | structural constituent of cytoskeleton | 8.48e-02 | 1.00e+00 | 3.501 | 1 | 8 | 91 |
GO:0001649 | osteoblast differentiation | 8.57e-02 | 1.00e+00 | 3.485 | 1 | 6 | 92 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 8.57e-02 | 1.00e+00 | 3.485 | 1 | 21 | 92 |
GO:0014069 | postsynaptic density | 9.73e-02 | 1.00e+00 | 3.294 | 1 | 3 | 105 |
GO:0030529 | ribonucleoprotein complex | 1.03e-01 | 1.00e+00 | 3.201 | 1 | 8 | 112 |
GO:0072562 | blood microparticle | 1.03e-01 | 1.00e+00 | 3.214 | 1 | 3 | 111 |
GO:0005819 | spindle | 1.03e-01 | 1.00e+00 | 3.201 | 1 | 7 | 112 |
GO:0044281 | small molecule metabolic process | 1.07e-01 | 1.00e+00 | 1.352 | 3 | 58 | 1211 |
GO:0000209 | protein polyubiquitination | 1.07e-01 | 1.00e+00 | 3.151 | 1 | 20 | 116 |
GO:0006325 | chromatin organization | 1.09e-01 | 1.00e+00 | 3.126 | 1 | 5 | 118 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 1.16e-01 | 1.00e+00 | 3.031 | 1 | 5 | 126 |
GO:0000790 | nuclear chromatin | 1.18e-01 | 1.00e+00 | 2.998 | 1 | 9 | 129 |
GO:0031982 | vesicle | 1.20e-01 | 1.00e+00 | 2.975 | 1 | 9 | 131 |
GO:0007507 | heart development | 1.27e-01 | 1.00e+00 | 2.890 | 1 | 7 | 139 |
GO:0006457 | protein folding | 1.30e-01 | 1.00e+00 | 2.849 | 1 | 7 | 143 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.35e-01 | 1.00e+00 | 2.790 | 1 | 32 | 149 |
GO:0005198 | structural molecule activity | 1.36e-01 | 1.00e+00 | 2.780 | 1 | 5 | 150 |
GO:0042981 | regulation of apoptotic process | 1.36e-01 | 1.00e+00 | 2.780 | 1 | 24 | 150 |
GO:0046777 | protein autophosphorylation | 1.43e-01 | 1.00e+00 | 2.705 | 1 | 7 | 158 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 1.49e-01 | 1.00e+00 | 2.642 | 1 | 7 | 165 |
GO:0030424 | axon | 1.50e-01 | 1.00e+00 | 2.634 | 1 | 4 | 166 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.54e-01 | 1.00e+00 | 2.591 | 1 | 20 | 171 |
GO:0004672 | protein kinase activity | 1.59e-01 | 1.00e+00 | 2.541 | 1 | 6 | 177 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 1.69e-01 | 1.00e+00 | 2.446 | 1 | 12 | 189 |
GO:0001701 | in utero embryonic development | 1.78e-01 | 1.00e+00 | 2.358 | 1 | 8 | 201 |
GO:0007067 | mitotic nuclear division | 1.99e-01 | 1.00e+00 | 2.182 | 1 | 14 | 227 |
GO:0043025 | neuronal cell body | 2.13e-01 | 1.00e+00 | 2.072 | 1 | 9 | 245 |
GO:0005975 | carbohydrate metabolic process | 2.20e-01 | 1.00e+00 | 2.026 | 1 | 9 | 253 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 2.32e-01 | 1.00e+00 | 1.937 | 1 | 15 | 269 |
GO:0019899 | enzyme binding | 2.38e-01 | 1.00e+00 | 1.895 | 1 | 12 | 277 |
GO:0005856 | cytoskeleton | 2.48e-01 | 1.00e+00 | 1.824 | 1 | 12 | 291 |
GO:0043231 | intracellular membrane-bounded organelle | 2.68e-01 | 1.00e+00 | 1.696 | 1 | 9 | 318 |
GO:0007268 | synaptic transmission | 2.78e-01 | 1.00e+00 | 1.634 | 1 | 6 | 332 |
GO:0005737 | cytoplasm | 2.92e-01 | 1.00e+00 | 0.451 | 5 | 110 | 3767 |
GO:0007155 | cell adhesion | 3.04e-01 | 1.00e+00 | 1.481 | 1 | 6 | 369 |
GO:0000278 | mitotic cell cycle | 3.20e-01 | 1.00e+00 | 1.398 | 1 | 48 | 391 |
GO:0055114 | oxidation-reduction process | 3.39e-01 | 1.00e+00 | 1.294 | 1 | 12 | 420 |
GO:0043066 | negative regulation of apoptotic process | 3.42e-01 | 1.00e+00 | 1.281 | 1 | 31 | 424 |
GO:0007596 | blood coagulation | 3.62e-01 | 1.00e+00 | 1.179 | 1 | 18 | 455 |
GO:0005524 | ATP binding | 3.63e-01 | 1.00e+00 | 0.667 | 2 | 60 | 1298 |
GO:0046872 | metal ion binding | 3.67e-01 | 1.00e+00 | 0.657 | 2 | 25 | 1307 |
GO:0042802 | identical protein binding | 3.80e-01 | 1.00e+00 | 1.090 | 1 | 20 | 484 |
GO:0006915 | apoptotic process | 4.23e-01 | 1.00e+00 | 0.892 | 1 | 33 | 555 |
GO:0045087 | innate immune response | 4.46e-01 | 1.00e+00 | 0.790 | 1 | 24 | 596 |
GO:0005634 | nucleus | 4.69e-01 | 1.00e+00 | 0.176 | 5 | 136 | 4559 |
GO:0005886 | plasma membrane | 4.71e-01 | 1.00e+00 | 0.259 | 3 | 45 | 2582 |
GO:0005615 | extracellular space | 6.18e-01 | 1.00e+00 | 0.106 | 1 | 17 | 957 |
GO:0008270 | zinc ion binding | 6.33e-01 | 1.00e+00 | 0.047 | 1 | 12 | 997 |
GO:0003677 | DNA binding | 7.09e-01 | 1.00e+00 | -0.242 | 1 | 28 | 1218 |